Thursday, October 19, 2017 4:03:49 PM
SOURCE: https://www.dailymarijuanaobserver.com/single-post/2017/10/19/CRBP-Is-Corbus-Pharmaceuticals-a-Cannabis-Stock-Kind-of
Shares of Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) are ripping today in reaction to the company's announcement of positive phase 2 trial results for its drug aiming to treat "rare, chronic, serious inflammatory and fibrotic diseases." Since this drug interacts with the body's natural endocannabinoid system, many investors are asking - is Corbus Pharmaceuticals a cannabis stock? Kind of.
Corbus' drug, called "anabasum," is a "novel synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes." As a endocannabinoid-mimetic drug, it binds with the body's cannabinoid receptors in order to take effect. By binding to the CB2 receptors on immune cells and fibroblasts, anabasum is far more effective in treating the above indications than the placebo.
In addition to being highly effective, "anabasum was well tolerated with no severe or serious side effects associated with the drug. No subjects dropped out." This is a great sign given how terrible the side effects of some drugs can be.
Corbus Pharmaceuticals Upside
According to the Cystic Fibrosis Foundation Patient Registry, in the United States, more than 30,000 people are living with cystic fibrosis (more than 70,000 worldwide). Additionally, approximately 1,000 new cases of CF are diagnosed each year.
The global cystic fibrosis therapeutics market is expected to reach USD 13.9 billion by 2025, according to a new report by Grand View Research. If this drug makes it through to FDA approval, "it could easily leap to $1 billion in annual sales," according to estimates from the Motley Fool.
Recent CRBP News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 08:03:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:35:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:30:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 10:13:33 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 10:07:02 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:45:24 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:41:54 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:08:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 08:19:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 09:12:51 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/05/2024 09:47:34 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/05/2024 09:21:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:12:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 10:27:41 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/01/2024 10:09:08 PM
- Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)] • Edgar (US Regulatory) • 01/31/2024 02:16:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:56:07 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/29/2024 09:40:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 12:31:08 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 12:30:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:47:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 01:45:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 10:25:47 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 09:57:41 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM